跳至主要内容
临床试验/ACTRN12624000358549
ACTRN12624000358549已完成Unknown

Efficacy and safety of transcutaneous electrical spinal cord neuromodulation (TESCoN) after spinal cord injury - a pilot study.

The University of Melbourne0 个研究点目标入组 5 人开始时间: 2024年3月28日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
15 Years 至 75 Years(—)
性别
All

入选标准

  • 1. Confrmed motor complete (American Spinal Injury Association Impairment Scale [AIS] grade A or B), or incomplete (AIS grade C or D) tetraplegia at the time of enrolment in the study with injury below C4 vertebral level.
  • 2. Subacute (3-6 months post-SCI), or chronic (12 months or more post-SCI)
  • 3. Aged between 15 and 75 years
  • 4. Have medical clearance to participate
  • 5. Able to comply with attendance requirements for the study

排除标准

  • 1. Other neurological disorders: signicant head injury, brachial plexus, or peripheral nerve injury
  • 2. Previous upper limb reconstructive surgery
  • 3. Pre-existing conditions: diabetes, elevated blood pressure
  • 4. Severe cognitive impairment that precludes consent or ability to follow instructions
  • 5. Skeletal or joint injury signicantly limiting range of movement of upper limbs
  • 6. Contraindications to stimulation (pacemaker, pregnancy, breast feeding, cancer).

研究者

相似试验

Driving functional recovery after spinal cord injury... | 临床试验